Generated by DeepSeek V3.2| Ravinder N. Maini | |
|---|---|
| Name | Ravinder N. Maini |
| Birth date | 22 April 1937 |
| Birth place | Punjab, British India |
| Nationality | British |
| Fields | Immunology, Rheumatology |
| Workplaces | Kennedy Institute of Rheumatology, Imperial College London |
| Alma mater | University of Cambridge, St Mary's Hospital Medical School |
| Known for | Anti-TNF therapy for rheumatoid arthritis |
| Awards | FRS, Knight Bachelor, Lasker-DeBakey Clinical Medical Research Award |
Ravinder N. Maini is a pioneering British immunologist and rheumatologist renowned for his transformative work in developing anti-TNF therapy for autoimmune diseases. His collaborative research with Marc Feldmann at the Kennedy Institute of Rheumatology fundamentally changed the treatment landscape for rheumatoid arthritis and other inflammatory conditions. For this groundbreaking contribution, he has received numerous prestigious accolades, including the Lasker-DeBakey Clinical Medical Research Award and a knighthood. Maini's career has been dedicated to bridging fundamental immunology with clinical application, holding significant positions at Imperial College London and influencing global medical practice.
Born in Punjab during the era of British India, Maini moved to the United Kingdom for his advanced education. He pursued his medical studies at St Mary's Hospital Medical School, which later became part of Imperial College London. Following his primary medical qualification, he undertook further scientific training at the University of Cambridge, where he developed a strong foundation in research methodology. This academic path equipped him with the dual expertise in clinical medicine and laboratory science that would define his future career.
Maini's most influential work began at the Kennedy Institute of Rheumatology in London, where he collaborated closely with immunologist Marc Feldmann. Their research focused on the cytokine networks active in the synovium of patients with rheumatoid arthritis. They identified tumor necrosis factor alpha (TNF-α) as a key driver of the disease's inflammation and joint destruction. This pivotal discovery led to the clinical development of infliximab, a monoclonal antibody that inhibits TNF, marking the birth of biologic therapy for autoimmune disorders. Maini later served as the Director of the Kennedy Institute of Rheumatology and held a professorship at Imperial College London. His work has had a profound impact on the treatment of other conditions like Crohn's disease, psoriatic arthritis, and ankylosing spondylitis.
In recognition of his revolutionary contributions to medicine, Maini has received some of the highest honors in science and healthcare. He was jointly awarded the Lasker-DeBakey Clinical Medical Research Award with Marc Feldmann in 2003. He was elected a Fellow of the Royal Society (FRS) in 2005 and was knighted as a Knight Bachelor in the 2013 New Year Honours. Other significant accolades include the Dr. Paul Janssen Award for Biomedical Research, the Crafoord Prize from the Royal Swedish Academy of Sciences, and the European Inventor Award from the European Patent Office. He is also an honorary fellow of the Royal College of Physicians.
Maini maintains a relatively private personal life, with public details focusing primarily on his professional achievements and his role as a mentor within the scientific community. He is known to have a family and has continued to reside in the United Kingdom throughout his distinguished career. His legacy is deeply embedded in the ongoing research and clinical practice of rheumatology departments worldwide.
Maini's extensive body of work is documented in numerous high-impact scientific papers. Key publications often co-authored with Marc Feldmann include seminal studies in journals like *The Lancet* and *Nature* that first demonstrated the efficacy of anti-TNF therapy in rheumatoid arthritis. Other influential papers have explored the mechanisms of cytokine blockade and the long-term outcomes of biologic treatments, published in periodicals such as *The New England Journal of Medicine*, *Annals of the Rheumatic Diseases*, and *Arthritis & Rheumatology*.
Category:British immunologists Category:British rheumatologists Category:Fellows of the Royal Society Category:Knights Bachelor Category:Lasker Award winners Category:Alumni of the University of Cambridge Category:Academics of Imperial College London Category:1937 births Category:Living people